| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.7B | $13.2B | $16.7B | $14.4B | $12.9B | $11.4B | $10.8B | $11.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.8B | $2.9B | $3.1B | $2.3B | $1.5B | $0.4B | $0.4B | $0.9B |
| EPS (Basic) | $2.75 | $4.44 | $4.81 | $6.65 | $4.03 | $12.93 | $0.21 | $3.51 |
| EPS (Diluted) | $2.75 | $4.42 | $4.79 | $6.62 | $4.01 | $12.88 | $0.21 | $3.25 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $110.9B | $96.2B | $87.2B | $78.6B | $72.0B | $66.6B | $65.7B | $60.6B |
| Current Assets | $34.8B | $5.3B | $5.5B | $5.9B | $4.4B | $4.5B | $3.3B | $3.6B |
| Cash & Equivalents | $0.0B | $1.6B | $0.2B | $0.4B | $0.6B | $1.0B | $0.1B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $21.9B | $9.7B | $10.1B | $9.9B | $10.0B | $6.8B | $9.2B | $7.5B |
| Stockholders' Equity | $31.6B | $31.2B | $28.7B | $27.1B | $26.0B | $23.4B | $19.9B | $17.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.6B | $4.9B | $6.2B | $1.1B | $3.8B | $2.6B | $3.1B | $3.4B |
| Investing Cash Flow | $-12.5B | $-9.1B | $-8.7B | $-5.0B | $-5.5B | $0.6B | $-4.6B | $-12.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $9.9B | $5.4B | $2.4B | $3.8B | $1.3B | $-2.4B | $1.5B | $9.0B |